# Human Evaluation of Drug Interaction Explanations

## Instructions

You will evaluate explanations of drug-drug interactions generated by two systems:
- **System A**: Template-based explanations
- **System B**: LLM-generated explanations

For each case, rate BOTH explanations on the following dimensions (1-5 scale):

### Faithfulness
_How accurately does the explanation represent the drug interaction facts?_

- **1**: Contains major factual errors
- **3**: Mostly accurate with minor issues
- **5**: Completely accurate

### Fluency
_How well-written and grammatical is the explanation?_

- **1**: Many grammar/spelling errors
- **3**: Generally readable
- **5**: Professional quality writing

### Completeness
_Does the explanation cover all important interactions and risks?_

- **1**: Missing major information
- **3**: Covers main points
- **5**: Comprehensive coverage

### Clarity
_How easy is it to understand the explanation?_

- **1**: Confusing or unclear
- **3**: Understandable with effort
- **5**: Crystal clear

### Clinical Utility
_Would this explanation help a clinician make decisions?_

- **1**: Not useful
- **3**: Somewhat helpful
- **5**: Very helpful for decision-making

---

## Case 1: warfarin, aspirin, metoprolol

**Ground Truth Risk Level**: HIGH
**Number of Interactions**: 3

### System A (Template)
```
ðŸŸ  HIGH RISK IDENTIFIED (Score: 0.63)

This medication combination has SIGNIFICANT interaction risks:
â€¢ Major drug interactions detected that require attention
â€¢ Monitoring and possible medication adjustments recommended

Key interactions:
- warfarin + acetylsalicylic acid: Major interaction
  Description: Acetylsalicylic acid may increase the anticoagulant activities of Warfarin....
- warfarin + metoprolol: Major interaction
  Description: Metoprolol may decrease the excretion rate of Warfarin w...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 2: warfarin, ibuprofen, lisinopril

**Ground Truth Risk Level**: HIGH
**Number of Interactions**: 3

### System A (Template)
```
ðŸŸ  HIGH RISK IDENTIFIED (Score: 0.72)

This medication combination has SIGNIFICANT interaction risks:
â€¢ Major drug interactions detected that require attention
â€¢ Monitoring and possible medication adjustments recommended

Key interactions:
- warfarin + ibuprofen: Contraindicated interaction
  Description: Ibuprofen may decrease the excretion rate of Warfarin which could result in a higher serum level....
- ibuprofen + lisinopril: Contraindicated interaction
  Description: The risk or severity of ...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 3: clopidogrel, omeprazole, aspirin

**Ground Truth Risk Level**: MODERATE
**Number of Interactions**: 1

### System A (Template)
```
ðŸŸ¡ MODERATE RISK (Score: 0.55)

This medication combination has some interaction concerns:
â€¢ Interactions detected but generally manageable
â€¢ Monitoring recommended

Key points:
- clopidogrel + omeprazole: Contraindicated interaction
  Description: The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a...

RECOMMENDATION: Discuss at next regular appointment with your provider.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 4: methotrexate, ibuprofen, prednisone

**Ground Truth Risk Level**: HIGH
**Number of Interactions**: 2

### System A (Template)
```
ðŸŸ  HIGH RISK IDENTIFIED (Score: 0.65)

This medication combination has SIGNIFICANT interaction risks:
â€¢ Major drug interactions detected that require attention
â€¢ Monitoring and possible medication adjustments recommended

Key interactions:
- ibuprofen + prednisone: Contraindicated interaction
  Description: The risk or severity of gastrointestinal irritation can be increased when Prednisone is combined with Ibuprofen....
- methotrexate + ibuprofen: Major interaction
  Description: The serum conce...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 5: lithium, ibuprofen, hydrochlorothiazide

**Ground Truth Risk Level**: HIGH
**Number of Interactions**: 3

### System A (Template)
```
ðŸŸ  HIGH RISK IDENTIFIED (Score: 0.67)

This medication combination has SIGNIFICANT interaction risks:
â€¢ Major drug interactions detected that require attention
â€¢ Monitoring and possible medication adjustments recommended

Key interactions:
- lithium cation + ibuprofen: Contraindicated interaction
  Description: Ibuprofen may decrease the excretion rate of Lithium cation which could result in a higher serum level....
- lithium cation + hydrochlorothiazide: Major interaction
  Description: Hydrochl...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 6: digoxin, amiodarone, furosemide

**Ground Truth Risk Level**: HIGH
**Number of Interactions**: 3

### System A (Template)
```
ðŸŸ  HIGH RISK IDENTIFIED (Score: 0.77)

This medication combination has SIGNIFICANT interaction risks:
â€¢ Major drug interactions detected that require attention
â€¢ Monitoring and possible medication adjustments recommended

Key interactions:
- digoxin + furosemide: Contraindicated interaction
  Description: The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin....
- amiodarone + furosemide: Contraindicated interaction
  Description: The risk or severity o...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 7: fluoxetine, tramadol, alprazolam

**Ground Truth Risk Level**: MODERATE
**Number of Interactions**: 0

### System A (Template)
```
ðŸŸ¡ MODERATE RISK (Score: 0.41)

This medication combination has some interaction concerns:
â€¢ Interactions detected but generally manageable
â€¢ Monitoring recommended

Key points:
No significant interactions found.

RECOMMENDATION: Discuss at next regular appointment with your provider.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 8: simvastatin, amiodarone, diltiazem

**Ground Truth Risk Level**: HIGH
**Number of Interactions**: 3

### System A (Template)
```
ðŸŸ  HIGH RISK IDENTIFIED (Score: 0.78)

This medication combination has SIGNIFICANT interaction risks:
â€¢ Major drug interactions detected that require attention
â€¢ Monitoring and possible medication adjustments recommended

Key interactions:
- amiodarone + diltiazem: Contraindicated interaction
  Description: The risk or severity of adverse effects can be increased when Amiodarone is combined with Diltiazem....
- simvastatin + amiodarone: Major interaction
  Description: The serum concentration of ...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 9: atorvastatin, amlodipine, lisinopril

**Ground Truth Risk Level**: LOW
**Number of Interactions**: 0

### System A (Template)
```
ðŸŸ¢ LOW RISK (Score: 0.34)

This medication combination appears generally safe:
â€¢ Only minor interactions detected
â€¢ Continue regular monitoring

Note: Always inform your healthcare providers of all medications you take.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 10: metformin, glipizide, lisinopril

**Ground Truth Risk Level**: MODERATE
**Number of Interactions**: 2

### System A (Template)
```
ðŸŸ¡ MODERATE RISK (Score: 0.50)

This medication combination has some interaction concerns:
â€¢ Interactions detected but generally manageable
â€¢ Monitoring recommended

Key points:
- metformin + lisinopril: Contraindicated interaction
  Description: The risk or severity of lactic acidosis can be increased when Lisinopril is combined with Metformin....
- glipizide + lisinopril: Major interaction
  Description: Lisinopril may decrease the excretion rate of Glipizide which could result in a higher seru...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 11: omeprazole, clopidogrel, metoprolol

**Ground Truth Risk Level**: MODERATE
**Number of Interactions**: 1

### System A (Template)
```
ðŸŸ¡ MODERATE RISK (Score: 0.57)

This medication combination has some interaction concerns:
â€¢ Interactions detected but generally manageable
â€¢ Monitoring recommended

Key points:
- omeprazole + clopidogrel: Contraindicated interaction
  Description: The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a...

RECOMMENDATION: Discuss at next regular appointment with your provider.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 12: sertraline, trazodone, alprazolam

**Ground Truth Risk Level**: MODERATE
**Number of Interactions**: 0

### System A (Template)
```
ðŸŸ¡ MODERATE RISK (Score: 0.41)

This medication combination has some interaction concerns:
â€¢ Interactions detected but generally manageable
â€¢ Monitoring recommended

Key points:
No significant interactions found.

RECOMMENDATION: Discuss at next regular appointment with your provider.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 13: gabapentin, pregabalin, duloxetine

**Ground Truth Risk Level**: LOW
**Number of Interactions**: 0

### System A (Template)
```
ðŸŸ¢ LOW RISK (Score: 0.31)

This medication combination appears generally safe:
â€¢ Only minor interactions detected
â€¢ Continue regular monitoring

Note: Always inform your healthcare providers of all medications you take.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 14: acetaminophen, ibuprofen, omeprazole

**Ground Truth Risk Level**: MODERATE
**Number of Interactions**: 0

### System A (Template)
```
ðŸŸ¡ MODERATE RISK (Score: 0.42)

This medication combination has some interaction concerns:
â€¢ Interactions detected but generally manageable
â€¢ Monitoring recommended

Key points:
No significant interactions found.

RECOMMENDATION: Discuss at next regular appointment with your provider.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 15: lisinopril, amlodipine, hydrochlorothiazide

**Ground Truth Risk Level**: LOW
**Number of Interactions**: 0

### System A (Template)
```
ðŸŸ¢ LOW RISK (Score: 0.36)

This medication combination appears generally safe:
â€¢ Only minor interactions detected
â€¢ Continue regular monitoring

Note: Always inform your healthcare providers of all medications you take.
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 16: metformin, sitagliptin, atorvastatin

**Ground Truth Risk Level**: MODERATE
**Number of Interactions**: 2

### System A (Template)
```
ðŸŸ¡ MODERATE RISK (Score: 0.50)

This medication combination has some interaction concerns:
â€¢ Interactions detected but generally manageable
â€¢ Monitoring recommended

Key points:
- metformin + atorvastatin: Contraindicated interaction
  Description: Metformin may increase the hypolipidaemic activities of Atorvastatin....
- sitagliptin + atorvastatin: Major interaction
  Description: The metabolism of Sitagliptin can be decreased when combined with Atorvastatin....

RECOMMENDATION: Discuss at next ...
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---

## Case 17: levothyroxine, calcium, vitamin d

**Ground Truth Risk Level**: MINIMAL
**Number of Interactions**: 0

### System A (Template)
```
Risk Level: MINIMAL (Score: 0.12)
```

### System B (LLM)
```
[LLM not available]
```

### Your Ratings

| Dimension | System A | System B |
|-----------|----------|----------|
| Faithfulness | ___ | ___ |
| Fluency | ___ | ___ |
| Completeness | ___ | ___ |
| Clarity | ___ | ___ |
| Clinical Utility | ___ | ___ |

**Comments (optional):**

_______________________________________

---
